人肺腺癌紫杉醇耐药细胞系的建立及生物学特性研究

摘要

目的 探讨紫杉醇(Taxol)诱导的人肺腺癌细胞A549耐药细胞系A549/Taxol生物学特性和耐药机制.方法 采用Taxol浓度递增间歇诱导法,建立A549/Taxol细胞系,MTT法测定耐药性,流式细胞术检测细胞周期,Transwell小室法检测细胞侵袭力,荧光定量RTPCR检测乳腺癌易感基因1(BRCA1)、受体相关蛋白80(RAP80)、微管相关蛋白T(Tau)、多药耐药基因1(MDR1)mRNA表达水平.结果 A549/Taxol细胞对Taxol及多西紫杉醇均有耐药性,对前者耐药性更强(RI=48.36 vs.27.21)(P＜0.01).与A549细胞相比,A549/Taxol细胞G1期的细胞比例增加[(50.56±0.25)％ vs.(57.75±0.16)％],而S期细胞比例减少[(37.85±1.48)％ vs.(30.21±1.87)％],细胞凋亡率增加幅度减小[(56.43±1.12)％ vs.(9.23±1.18)％],细胞侵袭力增强[(38.6±9.97)个vs.(116.8±21.73)个],BRCA1、RAP80 mRNA表达降低,而MDR1、Tau mRNA表达显著升高(P＜0.01).结论 成功建立Taxol耐药细胞系A549/Taxol,有助于进一步研究肺癌耐药机制.%Objective To explore the biological characteristics and mechanisms of drug resistance in Taxol-induced drug resistant human lung adenocarcinoma cell line (A549/Taxol). Methods The cell line A549/Taxol was established by intermittent-inducing method of gradually increasing the concentration of Taxol in vitro. Its drug resistance, cell cycle and cell invasion were detected by MTT assay, flow cytometry and transwell chamber, respectively. The expressions of BRCAl,RAP80,Tau and MDR1 mRNA were measured by quantitative RT-PCR. Results The cell line A549/Taxol was resistant to both Taxol and Docetaxel, which was more resistant to Taxol than that to Docetaxel(RI=48. 36 vs. 27. 21)(P<0. 01). Compared with cell line A549,in cell line A549/ Taxol,G1 phase cell fraction increased [(50. 56±0. 25)% vs. (57. 75 ± 0. 16)%],S phase cell fraction decreased[(37. 85 ± 1. 48)% vs. (30. 21 ± 1. 87)%],the increase in apoptosis rate was smaller[(56. 43 ± 1. 12)% vs. (9. 23 ± 1. 18)%],the ability of cell invasion increased[(38. 6 ± 9. 97) pieces vs. (116.8 ± 21.73) pieces], the levels of BRCA1 and RAP80 declined while the levels of MDR1 and Tau significantly increased (P<0. 01 ). Conclusion The cell line A549/Taxol has been established successfully,which is helpful in the further study on the mechanism for drug resistance.